Importantly, we demonstrated that pharmacological inhibition of MTA1 and its associated network by a natural dietary compound pterostilbene, exhibited chemopreventive and therapeutic efficacy as evident by the decreased severity of PIN and prevention of progression to carcinoma in pre-clinical Pten-loss mouse models of prostate cancer. This evidence concerns the gene PTEN and prostate cancer.